FMP-374

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameFMP-374
Drug Alias NameFMP-374FMP374
ClassificationOther
Mechanisms of ActionGlutamate [NMDA] receptor modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFundaMental Pharma GmbH
China Registration ClassN/A

Develop Information

Active CompaniesFundaMental Pharma GmbH
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A